Jacobson Pharma Announces FY2018 Interim Results
- Written by Reporters
Realizing Growth Strategies With Both Revenue and Net Profit Up
Declares Interim Dividend of HK0.9 cent per share
HONG KONG, CHINA - Media OutReach - 22 November 2017 - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; HKSE: 2633), a leading company engaged in the research, development, production, marketing and...

